Research output

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

  • Etop Lungscape Consortium
  • Kerr, K. M.
  • Dafni, U.
  • Schulze, K.
  • Thunnissen, E.
  • Bubendorf, L.
  • Hager, H.
  • Finn, S.
  • Biernat, W.
  • Vliegen, L.
  • Losa, J. H.
  • Marchetti, A.
  • Cheney, R.
  • Warth, A.
  • Speel, E.J.M.

  • Blackhall, F.
  • Monkhorst, K.
  • Lewintre, E. J.
  • Tischler, V.
  • Clark, C.
  • Bertran-Alamillo, J.
  • Meldgaard, P.
  • Gately, K.
  • Wrona, A.
  • Vandenberghe, P.
  • Felip, E.
  • De Luca, G.
  • Savic, S.
  • Muley, T.
  • Smit, E. F.
  • Dingemans, A.C.

  • Priest, L.
  • Baas, P.
  • Camps, C.
  • Weder, W.
  • Polydoropoulou, V.
  • Geiger, T. R.
  • Kammler, R.
  • Sumiyoshi, T.
  • Molina, M. A.
  • Shames, D. S.
  • Stahel, R. A.
  • Peters, S.

Associated organisations

    Research areas

  • non-small-cell lung cancer, multiplex mutation analysis, EGFR, KRAS, PIK3CA, prognosis molecular staging, CELL LUNG-CANCER, TYROSINE KINASE INHIBITORS, PREDICT SURVIVAL, KRAS MUTATIONS, ADENOCARCINOMA, OVEREXPRESSION, HETEROGENEITY, AMPLIFICATION, VALIDATION
View graph of relations

Details

Original languageEnglish
Pages (from-to)200-208
Number of pages9
JournalAnnals of Oncology
Volume29
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018